
Ceres Nanosciences
Founded Year
2008Stage
Grant - VIII | AliveTotal Raised
$24.07MLast Raised
$1.4M | 6 mos agoAbout Ceres Nanosciences
Ceres Nanosciences has developed and commercialized a nanoparticle technology, the Nanotrap, which provides biomarker capture and biofluid sample processing capabilities for a wide array of diagnostic applications and sample handling needs. The company was founded in 2008 and is based in Manassa, Virginia.
Missing: Ceres Nanosciences's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Ceres Nanosciences's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Ceres Nanosciences
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Ceres Nanosciences is included in 3 Expert Collections, including Medical Devices.
Medical Devices
9,046 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Omics
1,267 items
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Health IT
7,901 items
Ceres Nanosciences Patents
Ceres Nanosciences has filed 4 patents.
The 3 most popular patent topics include:
- Analytical chemistry
- Chromatography
- Dosage forms

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
11/13/2012 | Analytical chemistry, Chromatography, Mass spectrometry, Ion source, Molecular biology | Application |
Application Date | 11/13/2012 |
---|---|
Grant Date | |
Title | |
Related Topics | Analytical chemistry, Chromatography, Mass spectrometry, Ion source, Molecular biology |
Status | Application |
Latest Ceres Nanosciences News
Jan 26, 2023
Promega Corporation released a new system designed to help wastewater testing labs scale up their infectious disease surveillance by incorporating two technologies in a single kit. Promega pairs the company’s Maxwell HT chemistry with Ceres Nanosciences’ Nanotrap particles , a technology used for capturing and concentrating low-abundance analytes such as viral particles. Together, these technologies empower labs to purify pathogen nucleic acids from wastewater samples in high-throughput workflows, the company says. “Ceres has a technology that enables concentration of microbes from wastewater that is unique to the market,” says Brandon Krueger, Promega field support scientist, “so it worked quite well for Promega and Ceres to join together to make this a better process overall for wastewater testing labs.” The new system joins a growing Promega portfolio of technologies used for wastewater-based epidemiology, including multiple workflows for purification and amplification of viral nucleic acids. Using the new kit offered by Promega, wastewater testing labs use the Ceres Nanotrap particles to concentrate viral particles present in wastewater samples. Next, labs use the established Maxwell HT chemistry to purify nucleic acids such as DNA and RNA. Those nucleic acids can then be amplified and detected using methods such as quantitative polymerase chain reaction (qPCR) or digital PCR (dPCR), or used in sequencing applications. “As wastewater-based epidemiology has expanded, it has become clear that it is incredibly valuable to pair the reliable and easy-to-use Nanotrap particle concentration method with strong purification methods,” says Robbie Barbero, Ceres chief business officer. “We are very excited that labs can now get the Promega Maxwell HT chemistry and the Nanotrap technology in a single kit.” The kit is designed to be implemented on a variety of automated liquid handlers, allowing labs to save time and resources by automating all necessary preprocessing and postprocessing for detecting viral nucleic acid from wastewater samples via qPCR. Promega Field Support Scientists offer comprehensive support for labs implementing Promega chemistry on any liquid handling platform, including robot programming and process optimization. Share:
Ceres Nanosciences Frequently Asked Questions (FAQ)
When was Ceres Nanosciences founded?
Ceres Nanosciences was founded in 2008.
Where is Ceres Nanosciences's headquarters?
Ceres Nanosciences's headquarters is located at 9460 Innovation Drive, Manassas.
What is Ceres Nanosciences's latest funding round?
Ceres Nanosciences's latest funding round is Grant - VIII.
How much did Ceres Nanosciences raise?
Ceres Nanosciences raised a total of $24.07M.
Who are the investors of Ceres Nanosciences?
Investors of Ceres Nanosciences include National Institutes of Health, Small Business Innovation Research Awards, Paycheck Protection Program, Virginia Catalyst, GreyBird Ventures and 7 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.